Povidone
Identification
- Brand Names
- Clear Eyes Natural Tears, Colirio Ocusan, Minidrops, Refresh Lubricant, Stye
- Generic Name
- Povidone
- DrugBank Accession Number
- DB11061
- Background
Povidone, also known as polyvinylpyrrolidone (PVP) or polyvidone, is a synthetic water-soluble polymer made from the monomer N-vinylpyrrolidone used as a binder in many pharmaceutical tablets and lubricant in eye drops. It is also used in many technical applications with various roles as an adhesive, additive, and emulsifier. When in complex with iodine, Povidone-iodine displays antiseptic properties where the iodine, a bactericidal component, mainly contributes to this effect, and povidone acts as a carrier 1. Povidone-iodine can be found in over-the-counter topical solutions, ointment, pessaries, liquid soaps and surgical scrubs. The clinical effectiveness of Povidone-iodine on wound healing remains somewhat controversial, as it was demonstrated in a few clinical studies that the application of the compound in wounds was associated with impaired wound healing, reduced wound strength, or infection in open wounds 1.
The FDA withdrew its approval for the use of all intravenous drug products containing povidone.5 Other formulations of povidone continue to be available.
- Type
- Small Molecule
- Groups
- Approved, Withdrawn
- Synonyms
- 1-ethenyl-2-pyrrolidinone homopolymer
- 1-vinyl-2-pyrrolidinone polymer
- Polividone
- Povidona
- Povidone
- Povidone, unspecified
- Povidonum
- External IDs
- E-1201
- Ins no.1201
- INS-1201
Pharmacology
- Indication
When in complex with iodine, indicated for inducing antisepsis for prevention of infection in minor cuts, scrapes, and burns.
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Conditions
- Associated Therapies
- Contraindications & Blackbox Warnings
- Avoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events & improve clinical decision support.
- Pharmacodynamics
Povidone itself has no microbicidal activity. Povidone-iodine exhibits rapid, potent, broad-spectrum antimicrobial properties 2. The clinical effectiveness of povidon-iodine on wound healing remains somewhat controversial; in few clinical studies investigating the effects of povidone-iodine on wound healing, topical administration of the complex was associated with no significant infections, but slower healing and mild to moderate discomfort on application 1.
- Mechanism of action
Povidone-iodine is a water-soluble complex that mediates a bactericidal or virucidal action following the gradual liberation of free iodine from the complex at the application site to react with the pathogen 1. Please refer to the drug entry for Povidone-iodine for the full mechanism of action of the complex.
- Absorption
This pharmacokinetic data does not apply to povidone.
- Volume of distribution
This pharmacokinetic data does not apply to povidone.
- Protein binding
This pharmacokinetic data does not apply to povidone.
- Metabolism
This pharmacokinetic data does not apply to povidone.
- Route of elimination
This pharmacokinetic data does not apply to povidone.
- Half-life
This pharmacokinetic data does not apply to povidone.
- Clearance
This pharmacokinetic data does not apply to povidone.
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Oral LD50 in mouse, rat, and rabbit are >40 mg/kg, 100 mg/kg, and 1040 mg/kg, respectively MSDS. No cases of overdose in humans have been reported.
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- No interactions found.
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- International/Other Brands
- Vinisil
- Over the Counter Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image iVizia Dry Eye Solution / drops 25 mg/5mL Ophthalmic Similasan Corporation 2021-11-29 Not applicable US iVizia Dry Eye Solution / drops 50 mg/10mL Ophthalmic Similasan AG 2021-11-29 Not applicable US iVizia Dry Eye Solution / drops 50 mg/10mL Ophthalmic Laboratoires Thea 2021-11-29 Not applicable US iVizia Lubricant Eye for Severe Night Dry Eyes Solution, gel forming / drops 2.5 mg/0.5g Ophthalmic Similasan Corporation 2021-10-14 Not applicable US iVizia Lubricant Eye for Severe Night Dry Eyes Solution, gel forming / drops 2.5 mg/0.5g Ophthalmic Laboratoires Thea 2021-11-05 Not applicable US Moisture Eyes Lubricant Eye Drops Solution 20 mg/1mL Ophthalmic Costco Wholesale Company 2020-06-26 Not applicable US Soothe Hydration Solution 12 mg/1mL Ophthalmic Bausch & Lomb Incorporated 2011-05-02 Not applicable US Soothe Hydration Therapy Solution / drops 2 % w/v Ophthalmic Bausch & Lomb Inc Not applicable Not applicable Canada Soothe Long Lasting Solution 20 mg/1mL Ophthalmic Bauch & Lomb Incorporated 2013-06-01 Not applicable US Soothe Lubricant Eye Drops Solution / drops 2 g/100mL Ophthalmic Bausch & Lomb Incorporated 2019-07-01 Not applicable US - Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Advance Relief Eye Drops Povidone (1000 mg/100mL) + Dextran 70 (100 mg/100mL) + Polyethylene glycol 400 (1000 mg/100mL) + Tetrahydrozoline hydrochloride (50 mg/100mL) Solution / drops Ophthalmic WinCo Foods, LLC 2015-01-09 Not applicable US Advanced Relief Povidone (10 mg/1mL) + Dextran 70 (1 mg/1mL) + Polyethylene glycol 400 (10 mg/1mL) + Tetrahydrozoline hydrochloride (0.5 mg/1mL) Liquid Ophthalmic Kareway Product, Inc. 2018-05-30 Not applicable US Advanced relief Povidone (10 mg/1mL) + Dextran 70 (1 mg/1mL) + Polyethylene glycol 400 (10 mg/1mL) + Tetrahydrozoline hydrochloride (0.5 mg/1mL) Liquid Ophthalmic American Sales Company 2011-09-07 Not applicable US Advanced relief Povidone (10 mg/1mL) + Dextran 70 (1 mg/1mL) + Polyethylene glycol 400 (10 mg/1mL) + Tetrahydrozoline hydrochloride (0.5 mg/1mL) Liquid Ophthalmic Samchundang Pharm. Co., Ltd. 2010-08-29 Not applicable US Advanced Relief Eye Drops Povidone (1 % w/v) + Dextran 70 (0.1 % w/v) + Polyethylene glycol 400 (1 % w/v) + Tetrahydrozoline hydrochloride (0.05 % w/v) Solution Ophthalmic TEVA Canada Limited 2010-08-30 Not applicable Canada Advanced Relief Eye Drops Povidone (1 % w/v) + Dextran 70 (0.1 % w/v) + Polyethylene glycol 400 (1 % w/v) + Tetrahydrozoline hydrochloride (0.05 % w/v) Solution Ophthalmic Kc Pharmaceuticals, Inc. Not applicable Not applicable Canada Artifical Tears Povidone (0.06 g/1mL) + Polyvinyl alcohol (0.05 g/1mL) Solution / drops Ophthalmic medsource pharmaceuticals 2016-04-04 Not applicable US Artificial Tears Povidone (6 mg/1mL) + Polyvinyl alcohol (5 mg/1mL) Solution / drops Ophthalmic Kc Pharmaceuticals, Inc. 2003-11-25 Not applicable US Artificial Tears Povidone (0.6 g/100mL) + Polyvinyl alcohol (0.5 g/100mL) Solution Ophthalmic Nucare Pharmaceuticals,inc. 2020-01-02 Not applicable US Artificial Tears Povidone (6 mg/1mL) + Polyvinyl alcohol (5 mg/1mL) Solution / drops Ophthalmic Strategic Sourcing Services LLC 2012-03-01 2015-12-31 US
Categories
- Drug Categories
- Alkenes
- Artificial Tears
- Blood Substitutes
- Compounds used in a research, industrial, or household setting
- Hematologic Agents
- Hydrocarbons, Acyclic
- Macromolecular Substances
- Pharmaceutic Aids
- Pharmaceutical Preparations
- Plasma Substitutes
- Plastics
- Polymers
- Polyvinyls
- Pyrrolidines
- Pyrrolidinones
- Vinyl Compounds
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- FZ989GH94E
- CAS number
- 9003-39-8
References
- General References
- Kramer SA: Effect of povidone-iodine on wound healing: a review. J Vasc Nurs. 1999 Mar;17(1):17-23. [Article]
- Bigliardi PL, Alsagoff SAL, El-Kafrawi HY, Pyon JK, Wa CTC, Villa MA: Povidone iodine in wound healing: A review of current concepts and practices. Int J Surg. 2017 Aug;44:260-268. doi: 10.1016/j.ijsu.2017.06.073. Epub 2017 Jun 23. [Article]
- DailyMed: Moisture Eyes Lubricant Eye Drops (povidone 2%) [Link]
- DailyMed: Murine Tears (polyvinyl alcohol/povidone) eye drops [Link]
- Code of Federal Regulations 216.24: Drug products withdrawn or removed from the market for reasons of safety or effectiveness. [Link]
- External Links
- KEGG Drug
- D02295
- KEGG Compound
- C19509
- PubChem Substance
- 347911100
- 8610
- Wikipedia
- Polyvinylpyrrolidone
- MSDS
- Download (211 KB)
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 4 Completed Prevention Postpartum Endometritis 1 4 Completed Treatment Dry Eye Syndrome (DES) / Dry Eyes 1 4 Completed Treatment Dry Eyes 1 4 Completed Treatment Healthy Subjects (HS) 1 3 Completed Treatment Cognitive Dysfunctions 1 3 Completed Treatment Conjunctivitis, Viral 1 2 Completed Treatment Bacterial blepharitis 1 2 Completed Treatment Keratoconjunctivitis Sicca (KCS) 1 2 Recruiting Basic Science Nasal and Pharyngeal Microbiome 1 2 Terminated Treatment Coronavirus Disease 2019 (COVID‑19) / Infections, Coronavirus 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Liquid Ophthalmic Solution Topical Solution / drops Intraocular Solution Conjunctival; Ophthalmic 50 mg Solution / drops Ophthalmic 25 mg/5mL Solution / drops Ophthalmic 50 mg/10mL Solution, gel forming / drops Ophthalmic 2.5 mg/0.5g Solution / drops Ophthalmic Solution / drops Ophthalmic 50 mg/ml Solution / drops Ophthalmic Solution / drops; suspension / drops Ophthalmic 50 mg/ml Solution / drops Ophthalmic 20 mg/0.4ml Solution Conjunctival; Ophthalmic Solution Ophthalmic Solution / drops; suspension / drops Ophthalmic 10 ml Solution / drops; suspension / drops Ophthalmic 20 mg/ml Solution / drops Ophthalmic 20 mg/ml Solution Ophthalmic 12 mg/1mL Solution / drops Ophthalmic 2 % w/v Solution Ophthalmic 20 mg/1mL Solution / drops Ophthalmic 2 g/100mL Solution Conjunctival; Ophthalmic 5 mg Solution / drops; suspension / drops Ophthalmic 2 % Solution / drops; suspension / drops Ophthalmic 12 mg Solution / drops Ophthalmic 5 % Kit; solution / drops Ophthalmic Solution Topical 10 g - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
Property Value Source melting point (°C) 100 MSDS water solubility Soluble MSDS - Predicted Properties
- Not Available
- Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
Drug created at December 03, 2015 16:51 / Updated at June 03, 2023 08:16